IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP

Watchlist Manager
IOL Chemicals and Pharmaceuticals Ltd Logo
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Watchlist
Price: 348.2 INR 1.89% Market Closed
Market Cap: 20.4B INR
Have any thoughts about
IOL Chemicals and Pharmaceuticals Ltd?
Write Note

IOL Chemicals and Pharmaceuticals Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IOL Chemicals and Pharmaceuticals Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Operating Income
â‚ą1.4B
CAGR 3-Years
-34%
CAGR 5-Years
-21%
CAGR 10-Years
9%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Operating Income
â‚ą65B
CAGR 3-Years
28%
CAGR 5-Years
27%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Operating Income
â‚ą56.2B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
14%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Operating Income
â‚ą112.5B
CAGR 3-Years
13%
CAGR 5-Years
17%
CAGR 10-Years
4%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Operating Income
â‚ą27.8B
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
10%
M
Mankind Pharma Ltd
NSE:MANKIND
Operating Income
â‚ą21.5B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

IOL Chemicals and Pharmaceuticals Ltd
Glance View

Market Cap
20.4B INR
Industry
Pharmaceuticals

IOL Chemicals & Pharmaceuticals Ltd. engages in the manufacture of organic and inorganic chemical compounds. The company is headquartered in Ludhiana, Punjab and currently employs 2,316 full-time employees. The company went IPO on 2010-11-05. The firm is engaged in manufacturing and selling of organic chemicals, specialty, intermediates, and bulk drugs. Its product portfolio covers various therapeutic categories, such as Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant, amongst others. Its active pharma ingredients (API) product portfolio include Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its specialty chemical division include Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid. The firm caters to the pharmaceutical and specialty chemical requirements across both domestic and international markets. The company serves Austria, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland and others.

IOLCP Intrinsic Value
528.04 INR
Undervaluation 34%
Intrinsic Value
Price

See Also

What is IOL Chemicals and Pharmaceuticals Ltd's Operating Income?
Operating Income
1.4B INR

Based on the financial report for Jun 30, 2024, IOL Chemicals and Pharmaceuticals Ltd's Operating Income amounts to 1.4B INR.

What is IOL Chemicals and Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
9%

Over the last year, the Operating Income growth was -25%. The average annual Operating Income growth rates for IOL Chemicals and Pharmaceuticals Ltd have been -34% over the past three years , -21% over the past five years , and 9% over the past ten years .

Back to Top